Detail akcie CryoLife online

Business Summary: Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Artivion Inc revenues increased 18% to $116.3M. Net income applicable to common stockholders totaled $1.4M vs. loss of $504K. Revenues reflect Medical devices segment increase of 16% to $91.4M, Preservation services segment increase of 23% to $24.9M. Net Income reflects Interest expense decrease of 30% to $5.4M (expense), Fair Value Adjustments - Other Assets increase from $300K to $800K (income).